Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 211,307 | 160,602 | 148,813 | 277,592 | 235,639 |
| Marketable Securities | 54,319 | 106,507 | 144,782 | 77,108 | 151,202 |
| Receivables | 63,716 | 68,178 | 66,196 | 52,303 | 52,556 |
| Inventories | 51,381 | 27,004 | 23,816 | 13,272 | 20,879 |
| TOTAL | $432,822 | $399,697 | $423,816 | $458,539 | $497,643 |
| Non-Current Assets | |||||
| PPE Net | 30,238 | 31,406 | 30,778 | 32,449 | 33,657 |
| Intangibles | 219,942 | 197,797 | 220,797 | 197,797 | 197,797 |
| Other Non-Current Assets | 47,091 | 71,619 | 48,776 | 70,743 | 71,492 |
| TOTAL | $297,271 | $300,822 | $300,351 | $300,989 | $302,946 |
| Total Assets | $730,093 | $700,519 | $724,167 | $759,528 | $800,589 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 26,527 | 37,633 | 36,830 | 31,879 | 42,379 |
| Accrued Expenses | 124,868 | 92,747 | 93,636 | 125,235 | 114,703 |
| TOTAL | $159,235 | $138,385 | $139,018 | $164,650 | $164,625 |
| Non-Current Liabilities | |||||
| Long Term Debt | 393,350 | 392,658 | 391,990 | 391,319 | 390,652 |
| Other Non-Current Liabilities | 60,021 | 60,997 | 70,112 | 60,158 | 61,051 |
| TOTAL | $459,277 | $459,561 | $462,102 | $462,313 | $462,539 |
| Total Liabilities | $618,512 | $597,946 | $601,120 | $626,963 | $627,164 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 287,121 | 284,576 | 282,715 | 280,945 | 280,499 |
| Common Shares | 2,856 | 2,820 | 2,815 | 2,813 | 2,811 |
| Retained earnings | -2,628,654 | -2,585,422 | -2,532,490 | -2,476,625 | -2,443,339 |
| Other shareholders' equity | 4,231 | -6,661 | -12,022 | -38,995 | -17,157 |
| TOTAL | $111,581 | $102,573 | $123,047 | $132,565 | $173,425 |
| Total Liabilities And Equity | $730,093 | $700,519 | $724,167 | $759,528 | $800,589 |